TSX:BHC (Bausch Health Companies Inc.)

About BHC

Bausch Health Companies Inc. is a global company that develops manufactures and markets a range of pharmaceutical medical device and over-the-counter products primarily in the therapeutic areas of eye health gastroenterology and dermatology. We are delivering on our commitments as we build an innovative company dedicated to advancing global health. Our approximately 22000 employees are united around our mission of improving peoples lives with our health care products and we manufacture and market health care products directly or indirectly in approximately 100 countries. Five pillars or guiding principles represent the foundation on which we are realizing our mission as an organization: People Quality Health Care Outcomes Customer Focus Innovation and Efficiency.
  • Bausch Health Companies Inc. (TSX: BHC) Latest News

    Investing

    This 1 Company May Still Be the Best Contrarian Play of the Year

    Here's why Valeant Pharmaceuticals Intl Inc. (TSX:VRX)(NYSE:VRX) may still be one of the best contrarian plays for 2017.

    Read more »

    The Motley Fool
    Investing

    Can Joe Papa Make Valeant Pharmaceuticals Intl Inc. a High Flyer Again?

    Valeant Pharmaceuticals Intl Inc. (TSX:VRX)(NYSE:VRX) is starting to look like a great contrarian play. Should you load up today?

    Read more »

    The Motley Fool
    Investing

    What’s the Next Stop for Valeant Pharmaceuticals Intl Inc.?

    With a little tailwind, investors still need to be cautious of Valeant Pharmaceuticals Intl Inc. (TSX:VRX)(NYSE:VRX).

    Read more »

    The Motley Fool
    Investing

    Will Donald Trump Give Valeant Pharmaceuticals Intl Inc. a Much-Needed Lifeline?

    Valeant Pharmaceuticals Intl Inc. (TSX:VRX)(NYSE:VRX) stock jumped 28% this week. What’s brewing?

    Read more »

    The Motley Fool
    Investing

    Is Valeant Pharmaceuticals Intl Inc. a Viable Investment Opportunity?

    Valeant Pharmaceuticals Intl Inc. (TSX:VRX)(NYSE:VRX) continues to chip away at a staggering amount of debt and transition to a more…

    Read more »

    The Motley Fool
    Investing

    Valeant Pharmaceuticals Intl Inc. vs. Jean Coutu Group PJC Inc.: Is the Drug Maker or Drug Retailer a Buy?

    Valeant Pharmaceuticals Intl Inc. (TSX:VRX)(NYSE:VRX) is a drug producer, while Jean Coutu Group PJC Inc. (TSX:PJC.A) is a drug retailer.…

    Read more »

    The Motley Fool
    Investing

    Valeant Pharmaceuticals Intl Inc.: When Is a Good Time to Invest?

    Valeant Pharmaceuticals Intl Inc. (TSX:VRX)(NYSE:VRX) continues to achieve its goal of paying down its debt, but there's a lot of…

    Read more »

    The Motley Fool
    Investing

    Valeant Pharmaceuticals Intl Inc. Takes Another Step Closer to Death

    After unloading another business, Valeant Pharmaceuticals Intl Inc. (TSX:VRX)(NYSE:VRX) is another step closer to being crippled by the interest expenses.

    Read more »

    The Motley Fool
    Investing

    Get ‘Em While They’re Hot: Shares of Valeant Pharmaceuticals Intl Inc. Climb

    Valeant Pharmaceuticals Intl Inc. (TSX:VRX)(NYSE:VRX) has continued to make headway towards its proposed $5 billion debt-repayment schedule set for February…

    Read more »

    The Motley Fool
    Investing

    Valeant Pharmaceuticals Intl Inc. May Raise Another US$2 Billion to Pay Back Debt: Time to Buy?

    Valeant Pharmaceuticals Intl Inc. (TSX:VRX)(NYSE:VRX) made another deal. Is Valeant well positioned to meet its goal of debt repayment? Is…

    Read more »

    The Motley Fool
    Investing

    Contrarian Investors: Don’t Expect a Sudden Rebound in Valeant Pharmaceuticals Intl Inc.

    Valeant Pharmaceuticals Intl Inc. (TSX:VRX)(NYSE:VRX) appears to be getting cheaper by the day. Is it finally time to initiate a…

    Read more »

    The Motley Fool
    Investing

    Don’t Miss Out on This Bargain Stock Before it’s Too Late

    While Valeant Pharmaceuticals Intl Inc. (TSX:VRX)(NYSE:VRX) doesn't currently pay a dividend, the company has a very healthy cash flow stream,…

    Read more »